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chocardiography for Percutaneous Heart Pumps
mit K. Mehrotra, MD, Dipak Shah, MD, Lissa Sugeng, MD, Neeraj Jolly, MD
WO COMMERCIALLY AVA ILABLE PERCUTANEOUS HEART PUMPS include
andemHeart (CardiacAssist, Inc., Pittsburgh, Pennsylvania) and Impella 2.5 (Abiomed, Danvers,
assachusetts), and they currently are used to support high-risk percutaneous coronary interventions
r acutely failing ventricles. TandemHeart (Fig. 1) pumps blood out of the left atrium and ejects it into
he iliac artery. Impella 2.5 (Fig. 2) aspirates blood from the left ventricle and ejects it into the ascending
orta. Echocardiography adds signiﬁcant value in the safe placement of these devices, as well as
nderstanding the interplay between these heart pumps and cardiac hemodynamics.
Figure 1. Unprotected Left Main and Proximal Right Coronary Artery Percutaneous Coronary Intervention After the Placement
of a TandemHeart in a Patient With Cardiogenic Shock
For a complete legend to this ﬁgure, please see the following page.rom the Department of Medicine, Section of Cardiology, University of Chicago, Chicago, Illinois.
A
E
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 2 , N O . 1 1 , 2 0 0 9
N O V E M B E R 2 0 0 9 : 1 3 3 2 – 3
Mehrotra et al.
Echocardiography for Percutaneous Heart Pumps
1333ddress for correspondence: Dr. Neeraj Jolly, 5841 South Maryland Avenue, MC 5076, University of Chicago, Chicago, Illinois 60637.
-mail: njolly@medicine.bsd.uchicago.edu.
Figure 2. An 87-Year-Old Patient Who Underwent a High-Risk Percutaneous Intervention to His Left Coronary Artery With the Support of an
Impella 2.5 Heart Pump
Figure 1. (1) Fluoroscopic still image of the TandemHeart in place with its tip in the left atrium (LA) before the left main coronary artery intervention was per-
formed. (2) Fluoroscopic still image after successful revascularization of the left main coronary artery with an intracoronary stent. Two-dimensional echo images
were obtained at varying levels of support to demonstrate the impact of decreasing left ventricular (LV) pre-load on systolic function. With the TandemHeart
working at 2 l/min, the LV ejection fraction (EF) was 31% and, with support increased to 4 l/min, the patient’s LV ejection fraction was 9%. (3, 4) Apical 4-cham-
ber views showing LV dimensions at 2 l/min support at end diastole and end systole, respectively. (5, 6) Apical 4-chamber views showing LV dimensions at 4
l/min support at end diastole and end systole, respectively. This is a real-time echocardiographic demonstration of Frank-Starling law of cardiac physiology and
emphasizes the potential role of echocardiography in weaning LV assist support from these failing hearts as they recover after such procedures. Support should
not be so minimal, as shown in Online Video 1 (apical 4-chamber echocardiography at 2 l/min support), that the LV does not rest enough and recover from the
acute insult. At the same time, it may be important to avoid maximal support to the dysfunctional LV and cause a suctioning effect, which may be deleterious
to the overall cardiac hemodynamics. It is important to not suddenly change the support from maximum status, as shown in Online Video 2 (apical 4-chamber
echocardiography at 4 l/min) and to monitor LV systolic function as a clinical surrogate for cardiac contractility. In comparison with pulsatile pumps, continuous
ﬂow pumps such as TandemHeart are more dependent on the state of ventricular unloading and ﬁlling pressure and require more careful optimization of the
loading conditions to gain maximal support from the pump. Echocardiographic monitoring of LV systolic function is very helpful not only for achieving an opti-
mal use of the device for LV recovery but also for weaning the heart from this assist device.
Figure 2. Impella 2.5 is a coaxial pump that can transport up to 2.5 l/min of blood from the LV to the ascending aorta. (7 to 12) An 87-year-old patient who
underwent a high-risk procedure to his left coronary artery with the support of an Impella 2.5 heart pump (7). Before placement of Impella 2.5, echocardiogra-
phy is necessary to demonstrate the absence of any apical clot (8). The correct positioning of this device across the aortic valve, as demonstrated by echocardi-
ography (9), is essential to obtain its maximum beneﬁt meanwhile avoiding signiﬁcant aortic regurgitation. Color Doppler imaging in the parasternal long-axis
view demonstrates the turbulent stream of blood exiting from the catheter and is visualized as a colored mosaic pattern. It is important to position the catheter
such that the mosaic pattern is seen above the sinuses of Valsalva, as demonstrated in Online Video 3 and (9). Online Video 3 illustrates the artifact that is intro-
duced into the images because of the electromagnetic motor of the pump positioned in the ascending aorta. This artifact interferes in 2-dimensional echo and
Doppler images of the heart (10). Continuous-wave Doppler velocities across the mitral valve with varying levels of pump support provided by Impella 2.5 are
shown in (11 and 12). At a lower level of support, (11) demonstrates a maximal mitral valve inﬂow velocity of 79.9 cm/s and a velocity time integral (VTI) of 18.7
cm. With a greater level of support, (12) demonstrates an increase in the maximal mitral valve inﬂow velocity to 87.7 cm/s and an increase in the VTI to 24.4 cm.
The increase in transmitral inﬂow velocities and VTI with a greater level of support with the Impella 2.5 is Doppler echocardiographic demonstration of the
unloading of the LV by the axial pump. LAD  left anterior descending; other abbreviation as in Figure 1.
